BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19102704)

  • 1. Correlating AMPA receptor activation and cleft closure across subunits: crystal structures of the GluR4 ligand-binding domain in complex with full and partial agonists.
    Gill A; Birdsey-Benson A; Jones BL; Henderson LP; Madden DR
    Biochemistry; 2008 Dec; 47(52):13831-41. PubMed ID: 19102704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyr702 is an important determinant of agonist binding and domain closure of the ligand-binding core of GluR2.
    Frandsen A; Pickering DS; Vestergaard B; Kasper C; Nielsen BB; Greenwood JR; Campiani G; Fattorusso C; Gajhede M; Schousboe A; Kastrup JS
    Mol Pharmacol; 2005 Mar; 67(3):703-13. PubMed ID: 15591246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced efficacy without further cleft closure: reevaluating twist as a source of agonist efficacy in AMPA receptors.
    Birdsey-Benson A; Gill A; Henderson LP; Madden DR
    J Neurosci; 2010 Jan; 30(4):1463-70. PubMed ID: 20107073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The loss of an electrostatic contact unique to AMPA receptor ligand binding domain 2 slows channel activation.
    Holley SM; Ahmed AH; Srinivasan J; Murthy SE; Weiland GA; Oswald RE; Nowak LM
    Biochemistry; 2012 May; 51(19):4015-27. PubMed ID: 22512472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for AMPA receptor activation and ligand selectivity: crystal structures of five agonist complexes with the GluR2 ligand-binding core.
    Hogner A; Kastrup JS; Jin R; Liljefors T; Mayer ML; Egebjerg J; Larsen IK; Gouaux E
    J Mol Biol; 2002 Sep; 322(1):93-109. PubMed ID: 12215417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and crystallization of a non-GluR2 AMPA-receptor ligand-binding domain: a case of cryo-incompatibility addressed by room-temperature data collection.
    Gill A; Madden DR
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Sep; 64(Pt 9):831-5. PubMed ID: 18765917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of cleft closure of the GluA2 ligand-binding domain in the presence of full and partial agonists revealed by hydrogen-deuterium exchange.
    Ahmed AH; Ptak CP; Fenwick MK; Hsieh CL; Weiland GA; Oswald RE
    J Biol Chem; 2013 Sep; 288(38):27658-27666. PubMed ID: 23940029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rigid body essential X-ray crystallography: distinguishing the bend and twist of glutamate receptor ligand binding domains.
    Bjerrum EJ; Biggin PC
    Proteins; 2008 Jul; 72(1):434-46. PubMed ID: 18214958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core.
    Armstrong N; Gouaux E
    Neuron; 2000 Oct; 28(1):165-81. PubMed ID: 11086992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and Affinity of Two Bicyclic Glutamate Analogues at AMPA and Kainate Receptors.
    Møllerud S; Pinto A; Marconi L; Frydenvang K; Thorsen TS; Laulumaa S; Venskutonytė R; Winther S; Moral AMC; Tamborini L; Conti P; Pickering DS; Kastrup JS
    ACS Chem Neurosci; 2017 Sep; 8(9):2056-2064. PubMed ID: 28691798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution X-ray scattering evidence for agonist- and antagonist-induced modulation of cleft closure in a glutamate receptor ligand-binding domain.
    Madden DR; Armstrong N; Svergun D; Pérez J; Vachette P
    J Biol Chem; 2005 Jun; 280(25):23637-42. PubMed ID: 15755731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuning activation of the AMPA-sensitive GluR2 ion channel by genetic adjustment of agonist-induced conformational changes.
    Armstrong N; Mayer M; Gouaux E
    Proc Natl Acad Sci U S A; 2003 May; 100(10):5736-41. PubMed ID: 12730367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsecond-to-millisecond conformational dynamics demarcate the GluR2 glutamate receptor bound to agonists glutamate, quisqualate, and AMPA.
    Valentine ER; Palmer AG
    Biochemistry; 2005 Mar; 44(9):3410-7. PubMed ID: 15736951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of activation and selectivity in a ligand-gated ion channel: structural and functional studies of GluR2 and quisqualate.
    Jin R; Horning M; Mayer ML; Gouaux E
    Biochemistry; 2002 Dec; 41(52):15635-43. PubMed ID: 12501192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional structure of the ligand-binding core of GluR2 in complex with the agonist (S)-ATPA: implications for receptor subunit selectivity.
    Lunn ML; Hogner A; Stensbøl TB; Gouaux E; Egebjerg J; Kastrup JS
    J Med Chem; 2003 Feb; 46(5):872-5. PubMed ID: 12593667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Full and partial agonism of ionotropic glutamate receptors indicated by molecular dynamics simulations.
    Postila PA; Ylilauri M; Pentikäinen OT
    J Chem Inf Model; 2011 May; 51(5):1037-47. PubMed ID: 21500800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing the function, conformational plasticity, and dimer-dimer contacts of the GluR2 ligand-binding core: studies of 5-substituted willardiines and GluR2 S1S2 in the crystal.
    Jin R; Gouaux E
    Biochemistry; 2003 May; 42(18):5201-13. PubMed ID: 12731861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kainate induces various domain closures in AMPA and kainate receptors.
    Venskutonytė R; Frydenvang K; Hald H; Rabassa AC; Gajhede M; Ahring PK; Kastrup JS
    Neurochem Int; 2012 Sep; 61(4):536-45. PubMed ID: 22425692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Energetics of the cleft closing transition and the role of electrostatic interactions in conformational rearrangements of the glutamate receptor ligand binding domain.
    Mamonova T; Yonkunas MJ; Kurnikova MG
    Biochemistry; 2008 Oct; 47(42):11077-85. PubMed ID: 18823129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A molecular envelope of the ligand-binding domain of a glutamate receptor in the presence and absence of agonist.
    Abele R; Svergun D; Keinänen K; Koch MH; Madden DR
    Biochemistry; 1999 Aug; 38(34):10949-57. PubMed ID: 10460150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.